Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Breast Neoplasms 529Neoplasms 475Carcinoma, Non-Small-Cell Lung 394Prostatic Neoplasms 308Colorectal Neoplasms 296Lung Neoplasms 259Neoplasm Metastasis 218Ovarian Neoplasms 200Leukemia, Myeloid, Acute 199Pancreatic Neoplasms 187Multiple Myeloma 175Squamous Cell Carcinoma of Head and Neck 134Recurrence 132Stomach Neoplasms 131Brain Neoplasms 126Carcinoma, Hepatocellular 125Melanoma 124Endometrial Neoplasms 122Glioblastoma 118Triple Negative Breast Neoplasms 111Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 100Head and Neck Neoplasms 99Lymphoma 97Carcinoma, Renal Cell 97Urinary Bladder Neoplasms 93Sarcoma 90Glioma 88Lymphoma, Non-Hodgkin 82Rectal Neoplasms 81

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Disorders of Sex Development × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

NCT04717349 2026-05-01

Data Collection Study of Pediatric and Adolescent Gynecology Conditions

National Institutes of Health Clinical Center (CC)

Recruiting
11,000 enrolled

Congenital Abnormalities, Disorders of Sex Development

Data powered by HemOnc (CC BY 4.0) Colophon âš¡